The Eye Surgery That Got Cheaper Every Year
LASIK is the economics seminar hiding in a strip mall: elective, cash pay, advertised on price, and one of the only medical procedures whose real cost fell for decades while quality improved. The exception explains the rule.
The Anomaly
American healthcare prices inflate relentlessly, faster than wages, faster than almost everything. The famous exception sits in shopping centers under neon: LASIK, laser vision correction, elective, almost never covered by insurance, and paid in cash. Adjusted for inflation, its price has fallen or held flat for two decades while the technology went through multiple generations of improvement, outcomes improved, and complication rates declined. Economists cite it constantly, because it is the closest thing medicine has to a controlled experiment in what happens when patients actually shop.
Why This Market Behaves
Every feature that makes ordinary medicine price blind is absent here. The patient pays directly, so the patient cares about price. The procedure is standardized and outcomes are measurable, so providers can be compared. It is schedulable, never an emergency, so the buyer has time to compare. And because providers must attract rather than receive patients, they advertise, posting prices publicly, financing plans included, something almost unheard of elsewhere in American medicine. Under those conditions, medicine behaves like an industry: volume providers emerged, technology diffused, and price competition disciplined everyone.
| Condition | Ordinary medicine | LASIK |
|---|---|---|
| Who pays | Insurer, opaquely | Patient, directly |
| Prices visible | Rarely | Advertised |
| Shoppable | Often not | Entirely |
The Fine Print of the Miracle
The seminar has caveats worth their own lecture. Teaser pricing is endemic, the advertised per eye number often excludes the technology tier most patients end up choosing, a reminder that price competition breeds price obfuscation too. Quality is not uniform, and the cheapest provider is not automatically the right purchase for a procedure performed once on irreplaceable tissue. The pattern generalizes with those same caveats: cosmetic procedures, dental veneers, and other cash pay corners of medicine show similar price discipline, along with similar marketing pathologies. Competition disciplines prices; it also hires copywriters.
The point is not that LASIK providers are more virtuous than hospitals. It is that they face customers instead of payers, and the same physicians behave like an industry the moment the reimbursement system is out of the room.
What It Says About Everything Else
The honest lesson cuts in both directions. Cash pay competition works for procedures that are elective, standardized, and affordable out of pocket, and much of medicine is none of those things: nobody comparison shops a heart attack, and catastrophic costs are why insurance exists. But a meaningful band of care, imaging, routine procedures, elective surgery, sits within reach of LASIK style transparency, and reference pricing experiments and posted price rules keep trying to import the mechanism. The resistance they meet is a measure of who benefits from prices staying dark.
The Bottom Line
LASIK proved that medical prices can fall, that quality can rise while they do, and that the necessary condition is a patient who sees the price before deciding. It is a small market carrying a large argument: the exceptional behavior is not the strip mall surgeon advertising a price, it is the rest of a healthcare system where nobody can. The seminar has been running for twenty years; the enrollment problem is political.